DAPT
别名: GSI-IX, LY-374973
目录号:S2215 Purity: 99.99%
DAPT是一种新型γ-secretase抑制剂,抑制 Aβ产生,在HEK 293细胞中IC50为20 nM。DAPT可促进人类舌癌细胞的凋亡并调节自噬。
CAS: 208255-80-5
客户使用Selleck的DAPT发表文献378篇
- Nat Biotechnol, 2024 10.1038/s41587-024-02386-x
- Nature, 2022 603(7899):159-165
- Cell Discov, 2022 8(1):118
- Adv Mater, 2022 e2106829
- Cell Stem Cell, 2022 29(5):776-794.e13
- Signal Transduct Target Ther, 2021 6(1):10
- Immunity, 2021 S1074-7613(21)00344-7
- Cancer Cell, 2020 13;37(1):104-122e12
- Nature, 2019 565(7740):505-510
- Cell Res, 2019 29(2):110-123
- Cell Res, 2019 29(11):895-910
- Nat Metab, 2019 1(2):222-235
- Nature, 2018 563(7733):701-704
- Mol Cancer, 2018 17(1):169
- Gastroenterology, 2018 155(5):1508-1523
- Cell Stem Cell, 2018 23(4):544-556
- Blood, 2018 131(2):191-201
- Nat Neurosci, 2016 19(8):1060-72
- Circ Res, 2015 116(1):23-34
- Nat Med, 2014 20(4):350-9
- Nat Commun, 2024 15(1):9529
- J Clin Invest, 2024 134(18)e179860
- Theranostics, 2024 14(6):2544-2559
- Genome Biol, 2024 25(1):58
- MedComm (2020), 2024 5(5):e525
- Br J Cancer, 2024 10.1038/s41416-024-02576-z
- JCI Insight, 2024 9(10)e167598
- Stem Cell Res Ther, 2024 15(1):422
- Cell Biol Toxicol, 2024 41(1):1
- Stem Cell Reports, 2024 19(7):973-992
- Biochem Pharmacol, 2024 230(Pt 2):116577
- iScience, 2024 27(6):109967
- Int J Mol Sci, 2024 25(21)11363
- Biomolecules, 2024 14(1)95
- J Ethnopharmacol, 2024 S0378-8741(24)01253-4
- Am J Cancer Res, 2024 14(7):3433-3450
- Cancers (Basel), 2024 16(10)1885
- J Biol Chem, 2024 300(11):107788
- Antibodies (Basel), 2024 13(1)15
- Sci Rep, 2024 14(1):560
- Regen Ther, 2024 25:229-237
- Biology (Basel), 2024 13(9)684
- Nat Commun, 2023 14(1):439
- Mol Ther, 2023 S1525-0016(22)00716-X
- MedComm -2020), 2023 4(5):e346
- Int J Biol Sci, 2023 19(6):1941-1954
- Mol Ther Nucleic Acids, 2023 32:343-358
- J Transl Med, 2023 21(1):530
- Antioxidants (Basel), 2023 12(11)1979
- J Orthop Translat, 2023 42:31-42
- Neural Regen Res, 2023 18(10):2285-2290
- Commun Biol, 2023 6(1):43
- iScience, 2023 26(12):108532
- iScience, 2023 26(5):106662
- Arthritis Res Ther, 2023 25(1):63
- Stem Cells Int, 2023 2023:1496597
- Heliyon, 2023 9(3):e14169
- Stem Cells Dev, 2023 32(11-12):301-313
- Turk J Biol, 2023 47(4):290-300
- Sci Adv, 2023 10.1126/sciadv.adi1827
- STAR Protoc, 2023 4(2):102266
- Neuropsychopharmacol Rep, 2023 10.1002/npr2.12361
- bioRxiv, 2023 2023.09.12.557355
- Nat Commun, 2022 13(1):3117
- Nat Commun, 2022 13(1):2733
- J Extracell Vesicles, 2022 11(11):e12280
- Hepatology, 2022 10.1002/hep.32332
- Theranostics, 2022 12(17):7431-7449
- Dev Cell, 2022 57(2):260-276.e9
- Cancer Res, 2022 82(7):1174-1192
- EMBO Mol Med, 2022 14(9):e15687
- Mol Psychiatry, 2022 27(10):4009-4022
- Cell Death Dis, 2022 13(4):395
- Cell Rep, 2022 39(1):110608
- JCI Insight, 2022 e150363
- Elife, 2022 11e70341
- Front Immunol, 2022 13:816952
- Front Immunol, 2022 13:943510
- Clin Sci (Lond), 2022 136(7):455-471
- iScience, 2022 25(3):103867
- Front Pharmacol, 2022 13:902796
- Int J Mol Sci, 2022 23(14)7941
- Int J Mol Sci, 2022 23-1911333
- J Cell Mol Med, 2022 26(19):4949-4958
- Stem Cells, 2022 sxac069
- J Pers Med, 2022 12(2)258
- Front Aging Neurosci, 2022 14:1013943
- Development, 2022 dev.199735
- Molecules, 2022 27(10)3121
- Sci Rep, 2022 12-1:15139
- Sci Rep, 2022 12(1):7
- Invest Ophthalmol Vis Sci, 2022 63(10):14
- Dis Model Mech, 2022 15(8)dmm049436
- Hum Cell, 2022 10.1007/s13577-022-00671-y
- Biol Trace Elem Res, 2022 10.1007/s12011-022-03364-7
- Gastroenterol Rep (Oxf), 2022 10:goab052
- Toxicol Lett, 2022 365:46-60
- BMC Vet Res, 2022 18-1:307
- Neurosci Lett, 2022 778:136603
- In Vitro Cell Dev Biol Anim, 2022 58(2):124-135
- Mol Genet Metab Rep, 2022 33:100914
- Nat Commun, 2021 12(1):6839
- Neuron, 2021 109(12):1949-1962.e6
- J Clin Invest, 2021 146287
- Adv Sci (Weinh), 2021 8(21):e2102354
- Brain, 2021 awab062
- Ann Neurol, 2021 10.1002/ana.26047
- Cancer Res, 2021 canres.2823.2020
- Proc Natl Acad Sci U S A, 2021 118(22)e2026184118
- Cancer Lett, 2021 508:1-12
- Cell Death Dis, 2021 12(10):867
- Cell Rep, 2021 36(2):109360
- Mol Ther Nucleic Acids, 2021 25:554-566
- Cell Rep, 2021 37(5):109912
- Cell Rep, 2021 35(10):109224
- Elife, 2021 10e70729
- Stem Cell Res Ther, 2021 12(1):353
- Antioxidants (Basel), 2021 10(10)1532
- Cell Death Discov, 2021 7(1):225
- Stem Cell Reports, 2021 S2213-6711(21)00265-4
- J Genet Genomics, 2021 S1673-8527(21)00318-0
- Int J Mol Sci, 2021 22(2)E849
- Front Cell Dev Biol, 2021 9:648627
- Front Cell Neurosci, 2021 15:648210
- Cancers (Basel), 2021 13(9)2107
- Front Microbiol, 2021 12:692832
- Eur J Pharmacol, 2021 899:174058
- Macromol Biosci, 2021 e2100327
- Sci Rep, 2021 11(1):24305
- Hum Cell, 2021 34(6):1911-1918
- Front Neurosci, 2021 15:768262
- Hum Cell, 2021 10.1007/s13577-021-00579-z
- Hum Cell, 2021 10.1007/s13577-021-00639-4
- J Cell Commun Signal, 2021 10.1007/s12079-021-00628-0
- Clin Transl Sci, 2021 14(2):568-581
- Neuromolecular Med, 2021 10.1007/s12017-021-08671-1
- J Pharmacol Exp Ther, 2021 378(2):77-86
- Neuroscience, 2021 S0306-4522(21)00070-1
- Sci Adv, 2021 7(5)eabc9781
- Stem Cell Res, 2021 51:102174
- bioRxiv, 2021 10.1101/2021.02.09.430313
- bioRxiv, 2021 10.1101/2021.08.09.455691
- Nat Commun, 2020 11(1):5400
- Nat Commun, 2020 11(1):5129
- Nat Commun, 2020 11(1):5139
- Nat Commun, 2020 11(1):6211
- Cancer Res, 2020 canres.2910.2019
- Clin Transl Med, 2020 10(6):e181
- Haematologica, 2020 haematol.2019.243998
- Adv Healthc Mater, 2020 9(6):e1901658
- Phytomedicine, 2020 68:153182
- Stem Cell Res Ther, 2020 11(1):347
- Ecotoxicol Environ Saf, 2020 203:110930
- Neurobiol Dis, 2020 138:104785
- Cells, 2020 9(10)E2288
- Cells, 2020 9(2)
- Commun Biol, 2020 3(1):363
- Stem Cell Reports, 2020 15(2):408-423
- Cancer Cell Int, 2020 19;20:58
- J Clin Endocrinol Metab, 2020 dgaa656
- Int J Mol Sci, 2020 21(3)
- Biomolecules, 2020 10(8):E1182
- J Cell Mol Med, 2020 10.1111/jcmm.15626
- Mol Nutr Food Res, 2020 64(5):e1900655
- J Biomed Mater Res A, 2020 22
- J Biol Chem, 2020 jbc.RA120.015165
- Carcinogenesis, 2020 41(7):993-1004
- Sci Rep, 2020 10(1):1847
- Hum Cell, 2020 10.1007/s13577-020-00425-8
- Hum Cell, 2020 10.1007/s13577-020-00420-z
- Dis Model Mech, 2020 10.1242/dmm.040105
- Cell Cycle, 2020 19(1):1-14
- Oral Dis, 2020 10.1111
- Genes (Basel), 2020 22;11(2) pii: E120
- Cancer Manag Res, 2020 12:6655-6663
- Brain Sci, 2020 3;10(6):E344
- Biochem Biophys Res Commun, 2020 4;526(3):793-798
- Biochem Cell Biol, 2020 10.1139/bcb-2018-0398
- Braz J Med Biol Res, 2020 53(11):e9551
- Sci Adv, 2020 6(1):eaay3566
- Sci Adv, 2020 6(39)eabc5447
- Sci Adv, 2020 6(30):eaba7606
- Stem Cell Res, 2020 49:102027
- Nat Commun, 2019 10(1):4524
- Alzheimers Dement, 2019 15(9):1183-1194
- Hepatology, 2019 10.1002/hep.31037
- Acta Neuropathol, 2019 10.1007/s00401-019-01986-1
- Mol Ther, 2019 10.1016/j.ymthe.2019.08.011
- Cell Death Differ, 2019 10.1038/s41418-019-0388-4
- Cell Death Differ, 2019 10.1038/s41418-019-0419-1
- Adv Healthc Mater, 2019 8(19):e1900979
- PLoS Biol, 2019 17(9):e3000087
- Mol Ther Nucleic Acids, 2019 16:745-757
- Cell Prolif, 2019 52(3):e12581
- J Cell Biol, 2019 218(2):644-663
- Elife, 2019 10.7554/eLife.47970
- Oxid Med Cell Longev, 2019 2019:7973098
- Neurotherapeutics, 2019 16(3):808-827
- Mol Cancer Ther, 2019 18(7):1230-1242
- Mol Cancer Ther, 2019 18(11):2146-2157
- Front Pharmacol, 2019 10:370
- J Cell Physiol, 2019 234(12):21825-21837
- J Ethnopharmacol, 2019 232:145-154
- J Cell Mol Med, 2019 23(1):260-270
- Cancers, 2019 11(1)
- Endocrinology, 2019 160(12):2863-2876
- Carcinogenesis, 2019 10.1093/carcin/bgy157
- Life Sci Alliance, 2019 2(3)
- J Immunol, 2019 202(8):2460-2472
- Front Neurosci, 2019 13:867
- Front Physiol, 2019 9:1940
- Microb Pathog, 2019 103829
- PLoS One, 2019 14(12):e0226570
- Exp Cell Res, 2019 376(1):27-38
- Exp Cell Res, 2019 376(1):1-10
- Biomed Res Int, 2019 2019:4647252
- Biochem Biophys Res Commun, 2019 514(4):1160-1166
- Exp Ther Med, 2019 18(3):1884-1890
- J Surg Res, 2019 244:358-367
- Biol Pharm Bull, 2019 42(2):222-230
- Prog Neuropsychopharmacol Biol Psychiatry, 2019 94:109644
- Vet Sci, 2019 6(4)
- Nat Commun, 2018 9(1):3815
- Nat Commun, 2018 9(1):3839
- Nat Commun, 2018 9(1):2865
- Neuron, 2018 100(1):135-149
- Theranostics, 2018 8(17):4795-4804
- Dev Cell, 2018 45(5):580-594
- J Exp Clin Cancer Res, 2018 37(1):291
- PLoS Biol, 2018 16(9):e2006624
- Cancer Lett, 2018 433:165-175
- Acta Biomater, 2018 82:93-101
- Cell Death Dis, 2018 9(2):158
- Oncogene, 2018 37(38):5160-5174
- Cell Mol Life Sci, 2018 75(15):2813-2826
- JCI Insight, 2018 3(2)
- Elife, 2018 10.7554/eLife.36739
- Elife, 2018 10.7554/eLife.32490
- Elife, 2018 10.7554/eLife.38911
- Biomed Pharmacother, 2018 97:535-542
- J Infect Dis, 2018 218(2):312-323
- Int J Cancer, 2018 142(5):999-1009
- Biochim Biophys Acta Mol Basis Dis, 2018 1864(4 Pt A):975-986
- Stem Cell Reports, 2018 11(3):635-650
- Cancer Sci, 2018 109(4):1055-1065
- Int Immunopharmacol, 2018 60:26-33
- Oncotarget, 2018 9(26):18239-18253
- Stem Cells, 2018 36(8):1273-1285
- Curr Top Dev Biol, 2018 129:123-142
- Eur J Pharmacol, 2018 832:1-10
- Endocrinology, 2018 159(1):184-198
- Cell Signal, 2018 51:139-151
- Development, 2018 145(24)
- Sci Rep, 2018 8(1):14017
- Sci Rep, 2018 8(1):17987
- PLoS Genet, 2018 14(7):e1007485
- Neurochem Res, 2018 43(6):1269-1282
- Cell Physiol Biochem, 2018 51(2):763-777
- Front Neurosci, 2018 12:789
- Cytokine, 2018 111:434-444
- Exp Cell Res, 2018 372(2):141-149
- Neuroscience, 2018 394:206-219
- Fish Physiol Biochem, 2018 44(1):375-386
- Hear Res, 2018 361:66-79
- Biotechnol Appl Biochem, 2018 65(4):554-559
- Biol Open, 2018 7(9)
- Assay Drug Dev Technol, 2018 16(7):408-419
- Cancer Cell Microenviron, 2018 5(1)
- Curr Protoc Stem Cell Biol, 2018 44:2D.21.1-2D.21.17
- Nat Commun, 2017 8(1):2214
- Proc Natl Acad Sci U S A, 2017 114(11):2934-2939
- Proc Natl Acad Sci U S A, 2017 114(15):E3129-E3138
- Proc Natl Acad Sci U S A, 2017 114(18):4757-4762
- Genes Dev, 2017 31(17):1770-1783
- Cancer Lett, 2017 403:195-205
- Cancer Lett, 2017 390:115-125
- Biofabrication, 2017 9(2):025007
- Environ Pollut, 2017 221:26-36
- Cell Rep, 2017 21(1):259-273
- Mol Ther Nucleic Acids, 2017 9:365-378
- Mol Ther Nucleic Acids, 2017 8:211-219
- Cell Rep, 2017 20(7):1692-1704
- Br J Pharmacol, 2017 174(23):4308-4328
- Oncoimmunology, 2017 7(3):e1408745
- Stem Cells Transl Med, 2017 6(9):1803-1814
- Stem Cell Reports, 2017 8(3):548-560
- Stem Cell Reports, 2017 9(1):231-246
- Stem Cell Reports, 2017 8(2):264-277
- Stem Cell Reports, 2017 8(4):822-830
- Oncotarget, 2017 8(70):115140-115152
- Oncotarget, 2017 8(9):14941-14956
- Oncotarget, 2017 8(33):55405-55421
- Oncotarget, 2017 8(11):17873-17886
- Oncotarget, 2017 8(11):18248-18259
- J Cell Mol Med, 2017 21(8):1593-1604
- Sci Rep, 2017 7(1):8603
- Sci Rep, 2017 7:43926
- Oncol Rep, 2017 38(5):2975-2984
- Mol Hum Reprod, 2017 23(7):488-499
- Toxicol Appl Pharmacol, 2017 319:1-11
- PLoS One, 2017 12(11):e0187248
- Oncol Lett, 2017 13(4):2260-2268
- Dev Biol, 2017 428(1):148-163
- Dev Biol, 2017 421(1):52-66
- Neurosci Lett, 2017 653:220-227
- J Burn Care Res, 2017 38(6):e923-e933
- J Plast Surg Hand Surg, 2017 51(6):405-413
- Nat Commun, 2016 7:12231
- Nat Commun, 2016 7:11379
- Nat Commun, 2016 7:13796
- Neuron, 2016 92(6):1252-1265
- Genome Biol, 2016 17:80
- Clin Cancer Res, 2016 22(8):2083-95
- Cancer Res, 2016 76(21):6171-6182
- Cancer Res, 2016 76(2):440-52
- Proc Natl Acad Sci U S A, 2016 113(43):12250-12255
- Proc Natl Acad Sci U S A, 2016 113(42):E6457-E6466
- Oncogene, 2016 35(30):3944-54
- Front Cell Infect Microbiol, 2016 6:132
- Am J Physiol Cell Physiol, 2016 310(7):C520-41
- Oncotarget, 2016 7(45):73903-73911
- Oncotarget, 2016 7(9):10650-62
- Oncotarget, 2016 7(28):43220-43238
- Oncotarget, 2016 7(28):43731-43745
- Oncotarget, 2016 7(47):77749-77763
- Oncotarget, 2016 7(51):84594-84607
- Biochim Biophys Acta, 2016 1862(11):2158-2167
- Sci Rep, 2016 6:24704
- Development, 2016 143(2):244-54
- Development, 2016 143(21):4003-4015
- Development, 2016 143(3):398-410
- Development, 2016 143(23):4394-4404
- Clin Exp Immunol, 2016 183(2):280-93
- PLoS One, 2016 11(3):e0151147
- Mol Med Rep, 2016 14(1):689-96
- Brain Res, 2016 1634:34-44
- Dev Biol, 2016 411(2):231-245
- BMC Neurosci, 2016 17:16
- Can J Physiol Pharmacol, 2016 94(5):542-53
- Nat Commun, 2015 6:7333
- Nat Commun, 2015 6:7935
- J Clin Invest, 2015 125(2):796-808
- Genome Biol, 2015 16:127
- Breast Cancer Res, 2015 17:109
- J Invest Dermatol, 2015 135(6):1521-1532
- Oncotarget, 2015 6(10):7992-8006
- Oncotarget, 2015 6(17):14953-69
- Oncotarget, 2015 6(37):40283-94
- Stem Cells, 2015 33(2):403-15
- J Biol Chem, 2015 290(16):10216-28
- Development, 2015 142(15):2610-22
- Sci Rep, 2015 5:13749
- PLoS One, 2015 10(11):e0142594
- Mol Med Rep, 2015 12(2):2765-70
- Am J Transl Res, 2015 7(1):162-74
- Am J Transl Res, 2015 7(1):162-174
- Nat Commun, 2014 5:4697
- J Clin Invest, 2014 124(12):5453-65
- Proc Natl Acad Sci U S A, 2014 111(23):8518-23
- Oncogene, 2014 10.1038/onc.2014.319
- Oncotarget, 2014 5(2):363-74
- Stem Cells, 2014 32(1):301-12
- Exp Eye Res, 2014 123:121-30
- Dev Biol, 2014 386(1):111-22
- Leuk Res, 2014 38(8):970-6
- BMC Neurosci, 2014 15:108
- EMBO Mol Med, 2013 5(10):1502-22
- PLoS Biol, 2013 11(12):e1001727
- J Cell Biol, 2013 201(2):279-92
- Mol Cancer Res, 2013 11(3):282-93
- J Biol Chem, 2013 288(31):22836-48
- Carcinogenesis, 2013 34(7):1420-30
- Dis Model Mech, 2013 6(6):1494-506
- Clin Dev Immunol, 2013 2013:429373
- Adv Exp Med Biol, 2012 727:99-113
- EMBO Mol Med, 2011 3(4):189-200
- Exp Hematol, 2011 53(12):7476-83
- Development, 2010 137(4):561-8
化学信息&溶解度
分子量 | 432.46 |
分子式 | C23H26F2N2O4 |
CAS号 | 208255-80-5 |
Smiles | CC(C(=O)NC(C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F |
储存条件(自收到货起) | |
建议分装储备液,避免反复冻融! |
|
体外溶解度 | 批次: |
DMSO : 86 mg/mL ( 198.86 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 41 mg/mL Water : Insoluble DMSO : 86 mg/mL ( 198.86 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 39 mg/mL Water : Insoluble DMSO : 86 mg/mL ( 198.86 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 86 mg/mL Water : Insoluble DMSO : 86 mg/mL ( 198.86 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 43 mg/mL Water : Insoluble DMSO : 86 mg/mL ( 198.86 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 43 mg/mL Water : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
5%DMSO
40%PEG300
5%Tween80
50%ddH2O
浓度:0.55mg/ml
(1.27mM)
操作示例:以 1 mL 工作液为例,取50μL11mg/ml的澄清DMSO储备液加到400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入500μL ddH2O定容至 1 mL。工作液请现配现用!
|
|
5%DMSO
40%PEG 300
5%Tween80
50% ddH2O
浓度:2mg/ml
(4.62mM)
操作示例:以 1 mL 工作液为例,取 50 μL 40 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀使其澄清;向上述体系中加入50 μL Tween-80,混合均匀使其澄清;然后继续加入 500 μLddH2O定容至 1 mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。